[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367991-105":59,"doc-detail-367991-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unravelling-the-therapeutic-potential-of-dual-tgf-1-and-cxcr4-inhibition-in-breast-cancer-using-computational-strategies-research-article","Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies - research article","","Breast cancer incidence and mortality continue to rise, while the molecular drivers of progression and therapy resistance remain incompletely defined, especially regarding the combined contribution of key regulatory genes. This study applies integrative bioinformatics to evaluate TGFβ-1, IL19, CXCR4, BMP1, VCAN, and WNT2 in breast cancer and derive a rationale for targeted approaches. Differential expression, pan-cancer/pathway enrichment, and docking within PPI networks are used to clarify functional interactions, suggest therapeutic targets, and support dual inhibition strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unravelling-the-therapeutic-potential-of-dual-tgf-1-and-cxcr4-inhibition-in-breast-cancer-using-computational-strategies-research-article/367991/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unravelling-the-therapeutic-potential-of-dual-tgf-1-and-cxcr4-inhibition-in-breast-cancer-using-computational-strategies-research-article/367991.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the study focus on TGFβ-1 and CXCR4 in breast cancer?","Question",{"text":112,"@type":113},"TGFβ-1 and CXCR4 are implicated as critical factors in breast cancer tumorigenesis, and the work examines how their inhibition interferes with tumor-associated pathways in a synergistic way.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What computational analyses are performed to evaluate candidate genes?",{"text":117,"@type":113},"The study uses differential gene expression analysis, pan-cancer and pathway enrichment analyses, and molecular docking to understand functional interactions and potential therapeutic targets within protein-protein interaction networks.",{"name":119,"@type":110,"acceptedAnswer":120},"Which dual inhibition strategy does the study propose and what is its expected benefit?",{"text":121,"@type":113},"It suggests concomitant inhibition of TGFβ-1 and CXCR4 using D4476 and AMD3100, aiming to provide therapeutic value by modulating key signaling cascades.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367991,1791430669,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","OPEN ACCESS  \nCitation: Haq BU, Sofi S, Qayoom H, Jan N, Jan A, Aljasir M, et al. (2025) Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies. PLoS One 20(12): e0323665. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0323665  \nEditor: Antimo Migliaccio, Universita degli Studi della Campania Luigi Vanvitelli, ITALY Received: January 13, 2025  \nAccepted: July 25, 2025  \nPublished: December 5, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0323665  \nCopyright: © 2025 Haq et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nUnravelling the therapeutic potential of dual TGF β-1 and CXCR4 inhibition in breast cancer using computational strategies  \nBurhan Ul Haq1☯, Shazia Sofi1☯, Hina Qayoom1, Nusrat Jan1, Asma Jan1, Mohammad Aljasir2, Irshad Ahmad3, Abdullah Almilabairy4, Fuzail Ahmad5, Bader Alshehri6, Manzoor Ahmad Mir1*  \n1 Cancer Biology Laboratory, Bioresources Department, SBS, Kashmir University, Srinagar, India,  \n2 Department of Medical Laboratories, Qassim University, Buraidah, Kingdom of Saudi Arabia,  \n3 Department of Medical Rehabilitation Sciences, King Khalid University, Abha, Kingdom of Saudi Arabia, 4 Department of Family and Community Medicine, Faculty of Medicine, Al Baha University, Al Baha, Kingdom of Saudi Arabia, 5 Respiratory Care Department, College of Applied Sciences, Almaarefa University, Diriya, Saudi Arabia, 6 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia  \n☯ These authors contributed equally to this work.  \n* [drmanzoor@kashmiruniversity.ac.in](drmanzoor@kashmiruniversity.ac.in)  \nAbstract  \nBackground and rationale  \nThe incidence and mortality of breast cancer (BC) continue to increase, making ita matter of public health concern worldwide. Despite the various strides made in breast cancer (BC) research, the molecular mechanisms driving its progression remain incompletely understood, particularly the role of key regulatory genes in tumor development and therapy resistance. TGFβ-1, IL19, CXCR4, BMP1, VCAN, and WNT2 have been implicated to be instrumental to critical oncogenic pathways; however, their cumulative contribution toward the pathophysiology of BC has not yet been investigated. Therefore, the present study utilizes an integrative bioinformatics approach to decipher their functional relevance, providing a basis for targeted therapies.  \nMethods and analytical approach  \nTGF-β1, IL19, CXCR4, BMP1, VCAN, and WNT2 are among the important genes in BC that we have studied in great detail using bioinformatics techniques that detail differential gene expression analysis for their dysregulation in BC. Their broader oncogenic implications were then clarified by performing pan-cancer and pathway enrichment analyses. Molecular docking studies were employed to comprehend the functional interactions and potential therapeutic targets in protein-protein interaction (PPI) networks.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0323665](https://doi.org/10.1371/journal.pone.0323665) December 5, 2025 1 / 27  \nand reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the paper and its Supporting Information files.  \nFunding: This study was financially supported by the Anusadhan National Research Foundation-ANRF (SERB), Department of Science and Technology, Government of India, in the form of a grant (SERB/CRG- 2023/008460)","cbCait7YXzE28ghs","https://ap.wps.com/l/cbCait7YXzE28ghs","pdf",3512963,27,"English","# Abstract\n## Background and rationale\n## Methods and analytical approach\n## Key findings","[{\"question\":\"Why does the study focus on TGFβ-1 and CXCR4 in breast cancer?\",\"answer\":\"TGFβ-1 and CXCR4 are implicated as critical factors in breast cancer tumorigenesis, and the work examines how their inhibition interferes with tumor-associated pathways in a synergistic way.\"},{\"question\":\"What computational analyses are performed to evaluate candidate genes?\",\"answer\":\"The study uses differential gene expression analysis, pan-cancer and pathway enrichment analyses, and molecular docking to understand functional interactions and potential therapeutic targets within protein-protein interaction networks.\"},{\"question\":\"Which dual inhibition strategy does the study propose and what is its expected benefit?\",\"answer\":\"It suggests concomitant inhibition of TGFβ-1 and CXCR4 using D4476 and AMD3100, aiming to provide therapeutic value by modulating key signaling cascades.\"}]","Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies - research article | PDF",1790174219,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68513c4f82b22fa763e075937abc4e38.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a2c0e5235d90abecd1beb1dcf6cb017.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51ab1ed4356cec1177a65d835d544cfd.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86523ca3cf6b0499d58bb45aea1f41d5.webp",980,1268]